Competition authority nods Saudi Chemical’s acquisition of prescription rights for Cialis in Saudi Arabia

05/04/2022 Argaam
Logo of the General Authority for Competition

Logo of the General Authority for Competition

The General Authority for Competition issued a no-objection certificate to the acquisition of the prescription rights of Cialis in Saudi Arabia from Eli Lilly by Saudi Chemical Holding Co. (SCHC).

 

The Tadawul-listed firm announced today, April 5 completing an agreement to acquire all prescription rights of Cialis in the Kingdom from Eli Lilly, Argaam earlier reported.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.